Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control when compared to giving treatments over a longer period, according to breakthrough research led by the Universities of Sheffield and Leeds and Sheffield Teaching Hospitals NHS Foundation Trust.
Of Interest
In a First, Mitochondrial Mutation Tied to Melanoma Checkpoint Resistance
It often starts with something small—a dark spot on the skin that looks a little off.
Genetic Trait Linked to Immune Checkpoint Inhibitor Resistance Identified in Metastatic Melanoma Study
A study involving 1,225 patients with metastatic melanoma has identified a genetic trait linked to resistance against immune checkpoint inhibitors, a widely used form of immunotherapy.
Immunotherapy Improves Overall Survival in Women With Genital Tract Melanoma
Overall survival (OS) in women with genital tract melanoma (GTM) is improved with immunotherapy, according to study findings published in Melanoma Research.